ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,736,529, issued on Sept. 15, was assigned to Roche Diagnostics Operations Inc. (Indianapolis).

"Streptavidin-coated solid phases with a member of a binding pair" was invented by Frank Bergmann (Penzberg, Germany), Dieter Heindl (Penzberg, Germany), Tobias Oelschlaegel (Penzberg, Germany) and Johannes Stoeckel (Penzberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a solid phase coated with (strept)avidin and having attached thereto, by way of biotin:(strept)avidin interaction, a biotinylated first member of a binding pair, wherein the attached first member is capable of binding to a second member of the bindi...